Citi Assumes Cellectis (CLLS) at Neutral
Tweet
Share
E-mailGet Alerts CLLS Hot Sheet
Price: $3.18 --0%
Rating Summary:
12 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 19
Rating Summary:
12 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 19
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz assumes coverage on Cellectis (NASDAQ: CLLS) with a Neutral rating and a price target of $22.00.
For an analyst ratings summary and ratings history on Cellectis click here. For more ratings news on Cellectis click here.
Shares of Cellectis closed at $16.86 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Starts BioMerieux (BIM:FP) (BMXMF) at Neutral
- Piper Sandler Starts DiaSorin SpA (DIA:IM) (DSRLF) at Neutral
- Piper Sandler Starts Danaher (DHR) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
